Go Pro

Marchex, Inc. (NASDAQ:MCHX) Short Interest Down 35.6% in August

Marchex logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Marchex’s short interest fell 35.6% in August to 28,578 shares, representing 0.1% of shares outstanding and 1.5 days to cover.
  • The stock traded at $1.36, while the company’s latest quarter missed expectations with a loss of $0.01 per share and revenue of $11.0 million versus an expected $11.2 million.
  • Acuitas Investments initiated a 133,702-share stake, but analyst sentiment remained cautious: coverage includes one Hold and one Sell rating, producing a consensus “Reduce” rating.
  • Five stocks we like better than Marchex.

Marchex, Inc. (NASDAQ:MCHX - Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totaling 28,578 shares, a decrease of 35.6% from the August 15th total of 44,393 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily volume of 18,895 shares, the days-to-cover ratio is currently 1.5 days.

Marchex Stock Up 5.4%

Shares of NASDAQ MCHX traded up $0.07 during mid-day trading on Thursday, hitting $1.36. 95,762 shares of the company were exchanged, compared to its average volume of 20,989. The stock has a 50 day simple moving average of $1.73 and a 200-day simple moving average of $1.63. Marchex has a 1-year low of $1.15 and a 1-year high of $2.04. The firm has a market cap of $60.30 million, a price-to-earnings ratio of -11.33 and a beta of 1.86.

Marchex (NASDAQ:MCHX - Get Free Report) last announced its quarterly earnings data on Wednesday, August 12th. The technology company reported ($0.01) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.03). The firm had revenue of $11.00 million for the quarter, compared to analysts' expectations of $11.20 million. Marchex had a negative return on equity of 18.25% and a negative net margin of 12.44%.

Hedge Funds Weigh In On Marchex

A hedge fund recently bought a new stake in Marchex stock. Acuitas Investments LLC bought a new position in shares of Marchex, Inc. (NASDAQ:MCHX - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 133,702 shares of the technology company's stock, valued at approximately $207,000. Marchex makes up 14.7% of Acuitas Investments LLC's holdings, making the stock its 3rd largest position. Acuitas Investments LLC owned about 0.30% of Marchex at the end of the most recent reporting period. Hedge funds and other institutional investors own 73.46% of the company's stock.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a "sell (d-)" rating on shares of Marchex in a research note on Friday, July 17th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Reduce".

View Our Latest Stock Analysis on MCHX

About Marchex

(Get Free Report)

Marchex, Inc NASDAQ: MCHX is a conversation intelligence and analytics company that helps businesses understand and improve customer interactions. Its technology analyzes phone calls, text messages and other customer conversations to provide insights into marketing performance, lead quality, sales opportunities and service experiences.

The company offers solutions designed to help organizations acquire, engage and retain customers. Its products support call tracking, lead management, conversation analytics and artificial intelligence-powered analysis, enabling businesses to identify buying signals, evaluate customer interactions and improve operational and marketing decisions.

Marchex has historically focused on performance marketing and call-based analytics, evolving from its earlier digital marketing activities toward software and data solutions for businesses that rely on customer conversations.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marchex Right Now?

Before you consider Marchex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.

While Marchex currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines